Literature DB >> 17361

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.

O Hornykiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 17361     DOI： 10.1146/annurev.pa.17.040177.002553

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  7 in total

1.  Dexamphetamine-induced EEG arousal in rats: a possible new test model for potential anti-schizophrenic agents [proceedings].

Authors:  M G Baxter; A A Miller; P L Wheatley
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

2.  Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm.

Authors:  L Kokkinidis; R M Zacharko
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.

Authors:  S E Robinson; S Berney; R Mishra; F Sulser
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

4.  Dopamine receptors in canine caudate nucleus.

Authors:  H Maeno
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

Review 5.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

Review 6.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

7.  Conformation of dopamine at the dopamine receptor.

Authors:  H L Komiskey; J F Bossart; D D Miller; P N Patil
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.